{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:27:53Z","timestamp":1791912473467,"version":"4.3.4"},"reference-count":7,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle Nerve"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1002\/mus.25458","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T09:06:40Z","timestamp":1480064800000},"page":"E12-E13","source":"Crossref","is-referenced-by-count":17,"title":["Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment"],"prefix":"10.1002","volume":"55","author":[{"given":"Paolo E.","family":"Alboini","sequence":"first","affiliation":[{"name":"Institute of Neurology; Largo F. Vito, 1 - 00168, Catholic University Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[{"name":"Institute of Neurology; Largo F. Vito, 1 - 00168, Catholic University Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Damato","sequence":"additional","affiliation":[{"name":"Institute of Neurology; Largo F. Vito, 1 - 00168, Catholic University Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Iorio","sequence":"additional","affiliation":[{"name":"Institute of Neurology; Largo F. Vito, 1 - 00168, Catholic University Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Bartoccioni","sequence":"additional","affiliation":[{"name":"General Pathology; Catholic University; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"10.1002\/mus.25458-BIB0001|mus25458-cit-0001","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8\u2009T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1002\/mus.25458-BIB0002|mus25458-cit-0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1002\/mus.25458-BIB0003|mus25458-cit-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","article-title":"Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease","volume":"76","author":"Coskun","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1002\/mus.25458-BIB0004|mus25458-cit-0004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bcpt.12164","article-title":"Therapeutic targeting of the Jak\/STAT pathway","volume":"114","author":"Aittom\u00e4ki","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1002\/mus.25458-BIB0005|mus25458-cit-0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40265-015-0351-8","article-title":"Ruxolitinib: a review of its use in patients with myelofibrosis","volume":"75","author":"Plosker","year":"2015","journal-title":"Drugs"},{"key":"10.1002\/mus.25458-BIB0006|mus25458-cit-0006","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMc1412997","article-title":"Remission of recalcitrant dermatomyositis treated with ruxolitinib","volume":"371","author":"Hornung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1002\/mus.25458-BIB0007|mus25458-cit-0007","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"}],"container-title":["Muscle & Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.25458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mus.25458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:48:39Z","timestamp":1625460519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.25458"}},"subtitle":["MuSK-MG Recovery after Ruxolitinib"],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/mus.25458","archive":["Portico"],"relation":{},"ISSN":["0148-639X"],"issn-type":[{"value":"0148-639X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}